摘要
在内分泌恶性肿瘤中,甲状腺癌发病率最高、发病率增长最迅速。每一年的新发例数约占全身所有恶性肿瘤的1.1%,DTC占90%以上,DTC中主要包括85%的乳头状癌和10%的滤泡状癌。DTC患者10年生存率为90%,约10%出现转移,远处转移肺为主、骨次之,骨转移患者10年生存率仅13%~21%,这已成为患者死亡的主要原因。早期诊治尤为重要,现对DTC诊疗新进展简要综述,包括血清甲状腺球蛋白、促甲状腺激素、131I-WBS、18FPET/CT。
In endocrine malignancies, the incidence of thyroid cancer is the highest, and the incidence is the fastest growing. Every year the new number of cases accounted for about 1.1% of all malignant tumors, differentiated thyroid carcinoma accounted for more than 90%, consists of 85% papillary carcinomas and 10% papillary carcinoma. DTC patients with 10 year survival rate was 90%, about 10% had metastases. Metastasis of lung was mainly located in the distance, and bone took the second place. The 10 year survival rate of bone metastasis was only 13%~21%, which has become the main reason for the death of patients. Early diagnosis is particularly important, the new progress of DTC diagnosis and treatment are briefly reviewed, including serum thyroglobulin, thyroid stimulating hormone, 131I-Whole Body Scan, 18Fluorodeoxyglucose-Positron Emission Computerized Tomography/ Computed Tomography.
出处
《医学诊断》
2017年第3期60-64,共5页
Medical Diagnosis
基金
广西医疗卫生适宜技术研究与开发项目(S201415-06)。
